-
公开(公告)号:WO2023076663A1
公开(公告)日:2023-05-04
申请号:PCT/US2022/048394
申请日:2022-10-31
Applicant: LOCUS SOLUTIONS IPCO, LLC
Inventor: FARMER, Sean
Abstract: The subject invention provides topical therapeutic compositions and methods of their use for enhanced healing of wounds, including bums, and scars of the skin, wherein the compositions and methods utilize microbial biosurfactants. The invention reduces the healing time of skin wounds, reduces the appearance of scars, and improves other skin conditions such as acne, psoriasis and eczema.
-
公开(公告)号:WO2023059523A1
公开(公告)日:2023-04-13
申请号:PCT/US2022/045472
申请日:2022-09-30
Applicant: JDS THERAPEUTICS, LLC
Inventor: KOMOROWSKI, James R. , KOMOROWSKI, Haley
IPC: A61K38/40 , A23L33/135 , A23L33/00
Abstract: Compositions comprising lactoferrin are described herein, which can allow for the use of ingredients in a formulation that previously could not be used, or combined together without encountering stability problems. The lactoferrin can also be included so as to eliminate the need for capsule-in-capsule formulations or embodiments comprising lactoferrin and a probiotic. As described herein, certain embodiments of the disclosure can comprise an active ingredient. An active ingredient can comprise one or more of a probiotic formulation, nutritional supplement, and a foodstuff. In certain embodiments, a probiotic formulation, nutritional supplement, and/or foodstuff. In certain embodiments, an active ingredient is a high water activity ingredient.
-
公开(公告)号:WO2023036981A1
公开(公告)日:2023-03-16
申请号:PCT/EP2022/075283
申请日:2022-09-12
Inventor: GRILC, Blaz , BJELOSEVIC, Maja , ROSKAR, Robert , OSEL, Nika , KRISTL, Albin , GASPERLIN, Mirjana
Abstract: The present invention generally relates to enteric-coated particles containing lactoferrin. More specifically, the present invention provides an enteric-coated particle comprising (or consisting essentially of): a) a core comprising (or consisting essentially of) an inert core-forming material selected from cellulose polymer, sugar, sugar alcohol, starch and carnauba wax; b) a first coating layer substantially covering the core and comprising (or consisting essentially of) b-1) lactoferrin, b- 2) a pharmaceutically acceptable binder and optionally b-3) one or more other suitable excipients, such as a plasticizer; and c) a second coating layer substantially covering the first coating layer and comprising (or consisting essentially of) c-1) an enteric coating material, and optionally c-2) one or more suitable excipients, such as a plasticizer and/or an anti-tacking agent. The present invention further provides pharmaceutical compositions and oral dosage forms comprising one or more particles according to the present invention.
-
公开(公告)号:WO2022253344A1
公开(公告)日:2022-12-08
申请号:PCT/CN2022/097031
申请日:2022-06-03
Applicant: 苏州大学
Abstract: 一种装载溶瘤肽的聚合物囊泡及其与免疫佐剂、抗体的联合药物与应用。将聚合物溶液与溶瘤肽溶液混合,然后透析,得到装载溶瘤肽的聚合物囊泡;将聚合物溶液与免疫佐剂溶液混合,然后透析,得到装载免疫佐剂的聚合物囊泡。联合药物系统给药方法能够有效靶向肿瘤处并重塑肿瘤微环境,从而实现了强效而长期的免疫记忆;拓宽溶瘤肽和CpG ODNs的使用窗口,为无法瘤内注射的肿瘤或是转移性浸润的肿瘤提供了一种新的治疗方案。
-
公开(公告)号:WO2022167925A1
公开(公告)日:2022-08-11
申请号:PCT/IB2022/050853
申请日:2022-02-01
Applicant: DISRUPTIVE TECHNOLOGICAL ADVANCES IN LIFE SCIENCE SRL , FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
Inventor: RUOCCO, Giancarlo , BOFFI, Alberto
IPC: A61K31/7012 , A61K9/00 , A61K31/716 , A61K31/734 , A61K33/30 , A61K38/40 , A61K45/06 , A61P31/14 , A61P31/16
Abstract: The present invention relates to the association of lactoferrin, at least one polysaccharide or salts thereof and at least one sialic acid or salts thereof in order to increase the stability of lactoferrin and consequent bioavailability of the same. The present invention further relates to pharmaceutically compositions comprising said association and the use thereof.
-
6.
公开(公告)号:WO2022091023A1
公开(公告)日:2022-05-05
申请号:PCT/IB2021/060035
申请日:2021-10-29
Applicant: APHARM SRL
Inventor: SCARPIGNATO, Carmelo
Abstract: Subject-matter of the present invention is a combination of active ingredients, the nutraceutical and/or pharmaceutical compositions containing it and their use to sustain and strengthen the functionality of the immune system and/or as coadjuvants in the prevention and/or treatment of viral and/or bacterial infections.
-
公开(公告)号:WO2021185876A1
公开(公告)日:2021-09-23
申请号:PCT/EP2021/056745
申请日:2021-03-16
Inventor: AO, Zihua , BRINK, Lauren Roukia , SHAH, Neil , ULPH, Caroline Elizabeth
Abstract: The present application provides lactoferrin, and compositions comprising lactoferrin, for use in the treatment and/or prevention of the 2019 novel coronavirus (COVID-19) infection in a subject.
-
公开(公告)号:WO2020246585A1
公开(公告)日:2020-12-10
申请号:PCT/JP2020/022294
申请日:2020-06-05
Applicant: 森永乳業株式会社
IPC: A23C9/152 , A61P1/04 , A61P3/02 , A61P31/00 , A61P31/14 , A61P43/00 , A23L33/125 , A23L33/19 , A61K38/40 , A61K31/702
Abstract: ヒトを含む動物の感染症の原因となる病原性ウィルス等への感染を予防する技術を提供することを課題とする。ラクトフェリン及び/又はラクトフェリン加水分解物と、ヒトミルクオリゴ糖とを含有する、栄養組成物。好ましくは、前記ヒトミルクオリゴ糖は、2'-フコシルラクトース、3-フコシルラクトース、3'-シアリルラクトース、6'-シアリルラクトースからなる群から選択される一種又は二種以上を含む。本栄養組成物は、感染予防用組成物、特にウィルス感染予防用組成物として使用できる。
-
公开(公告)号:WO2020126536A1
公开(公告)日:2020-06-25
申请号:PCT/EP2019/083932
申请日:2019-12-06
Applicant: SOCIETE DES PRODUITS NESTLE S.A.
Inventor: BOVETTO, Lionel, Jean, René , O'REGAN, Jonathan , PECQUET, Sophie
Abstract: The invention relates to a nutritional composition for infants and young children comprising proteins, carbohydrates and lipids, wherein said proteins comprise ionic complexes of lactoferrin with acid milk proteins, said complexes having a negative charge at the pH of the infant formula. The nutritional composition is used for providing a satiety feeling and/or a better sleep and/or limiting nocturnal awaking in infants or young children.
-
公开(公告)号:WO2020116511A1
公开(公告)日:2020-06-11
申请号:PCT/JP2019/047425
申请日:2019-12-04
Applicant: 森永乳業株式会社
IPC: A61P31/14 , A61P43/00 , A61K35/745 , A61K35/747 , A23L33/135 , A23L33/19 , A61K38/40
Abstract: 本発明は、ノロウイルスがヒトに感染することを抑制できるノロウイルス感染抑制用組成物を提供することを課題とし、該課題を、ビフィドバクテリウム・ブレーベ、ビフィドバクテリウム・ロンガム・サブスピーシーズ・インファンティス、ビフィドバクテリウム・アニマリス、ビフィドバクテリウム・ビフィダム、ビフィドバクテリウム・カテニュラータム、ラクトバチルス・ガセリ、ラクトバチルス・ヘルベティカス、ラクトバチルス・デルブリッキィ・サブスピーシーズ・ブルガリカス及びラクトバチルス・パラカゼイから成る群から選択される一又は複数の細菌を有効成分とするノロウイルス感染抑制用組成物で解決する。
-
-
-
-
-
-
-
-
-